Review on the Drug Intolerance and Vaccine Development for the Leishmaniasis.

Kumari, Priya; Mamud, Afrin; Jha, Anupam Nath

Kumari, Priya; Mamud, Afrin; Jha, Anupam Nath.

Afiliación

Kumari P; Centre of Sustainable Polymers, Indian Institute of Technology, Guwahati, Assam, India.
Mamud A; Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, Assam, India.
Jha AN; Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, Assam, India.

Curr Drug Targets ; 24(13): 1023-1031, 2023.

Article en En | MEDLINE | ID: mdl-37823567

Asunto(s)

Leishmania donovani; Leishmaniasis Visceral; Leishmaniasis; Vacunas; Animales; Perros; Humanos; Leishmaniasis/tratamiento farmacológico; Leishmaniasis/prevención & control; Leishmaniasis Visceral/tratamiento farmacológico; Leishmaniasis Visceral/prevención & control; Enfermedades Desatendidas; Vacunas/uso terapéutico; Desarrollo de Vacunas

Palabras clave

L. donovani.; Leishmania; kala-azar; neglected tropical disease (NTD); vaccines; visceral leishmaniasis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leishmania donovani / Vacunas / Leishmaniasis / Leishmaniasis Visceral Límite: Animals / Humans Idioma: En Revista: Curr Drug Targets Asunto de la revista: TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: India

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google